Unless specifically excepted by state or
federal law or regulation or more specifically included in another
schedule, the following controlled substances are listed in schedule I:
(2) SYNTHETIC OPIATES. Any material, compound, mixture
or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters,
ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically
possible within the specific chemical designation:
(ag) Acetylmethadol;
(aj) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
(am) Allylprodine;
(b) Alphacetylmethadol (except levo-alphacetylmethadol
(LAAM));
(bm) Alphameprodine;
(c) Alphamethadol;
(cm) Benzethidine;
(d) Betacetylmethadol;
(dm) Betameprodine;
(e) Betamethadol;
(em) Betaprodine;
(et) Brorphine;
(f) Clonitazene;
(fm) Dextromoramide;
(gm) Diampromide;
(h) Diethylthiambutene;
(hg) Difenoxin;
(hm) Dimenoxadol;
(j) Dimepheptanol;
(jm) Dimethylthiambutene;
(k) Dioxaphetyl butyrate;
(km) Dipipanone;
(m) Ethylmethylthiambutene;
(n) Etoxeridine;
(nd) Fentanyl analogs, including any compound, except compounds scheduled elsewhere in this chapter, structurally derived
from fentanyl by replacement of the phenyl portion of the
phenethyl group by any monocycle whether or not further substituted in or on the monocycle; by substitution in or on the
phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo,
haloalkyl, amino or nitro groups; by substitution in or on the
piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy,
halo, haloalkyl, amino or nitro groups; by replacement of the aniline ring with any aromatic monocycle whether or not further
substituted in or on the aromatic monocycle; by replacement of
the N-propionyl group by another acyl group; or by any combination of these modifications. Substances specified under this
paragraph include all of the following:
1. Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2phenylethyl)-4-piperidinyl]-N-phenylacetamide);
2. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylacetamide);
3. Acryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]-2-propenamide);
3m. Alpha-methyl butyryl fentanyl (2-methyl-N-(1phenethylpiperidin-4-yl)-N-phenylbutanamide);
4. Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4piperidinyl]-N-phenylpropanamide);
5. Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
6. Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4piperidinyl]-N-phenylpropanamide);
7. Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
8. Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
8m. Beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide);
9. Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbutyramide);
9m. Crotonyl Fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-
N-phenylbut-2- enamide);
10. Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylcyclopentanecarboxamide);
10d. Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-
N-phenylcyclopropanecarboxamide);
10m. 2’,5’-dimethoxyfentanyl (N-(1-(2,5dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
10p. 4-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2phenylethyl)piperidin-4-yl]-butyramide);
10t. 4-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide);
11. Furanyl fentanyl (N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]furan-2-carboxamide);
11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylfuran-3-carboxamide);
12. Isobutyryl fentanyl (2-methyl-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]-propanamide);
12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin4-yl)-N-phenylbutanamide);
12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1phenethylpiperidin-4-yl)propionamide);
12p. Meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1phenethylpiperidin-4-yl)furan-2-carboxamide);
12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-
(1-phenethylpiperidin-4-yl)isobutyramide);
12w. Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]-acetamide);
12y. 3-methylbutyryl fentanyl (N-[3-methyl-1-(2phenylethyl)piperidin-4-yl]-N-phenylbutyramide);
13. 4-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1phenethylpiperidin-4-yl)butyramide);
14. 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4piperidinyl]-N-phenylpropanamide);
15. 3-methylthiofentanyl (N-{3-methyl-1-[2-(2thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
16. Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-[1-(2phenylethyl)piperidin-4-yl]-acetamide);
16h. Ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1phenethylpiperidin-4-yl)propionamide);
16m. Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1phenethylpiperidin-4-yl)propionamide);
16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-
(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
16q. Ortho-methylcyclopropyl fentanyl (N-(2methylphenyl)-N-(1-phenethylpiperidin-4yl)cyclopropanecarboxamide);
16r. Para-chlorofentanyl (N-(4-chlorophenyl)-N-(1phenethylpiperidin-4-yl)propionamide;
16s. Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-
(1-phenethylpiperidin-4-yl)isobutyramide);
17. Para-fluorofentanyl (N-[1-(2-phenylethyl)-4piperidinyl]-N-(4-fluorophenyl)propanamide);
17d. Para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)pentanamide);
17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-
N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-
N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
18. Tetrahydrofuran fentanyl (N-(1-phenethylpiperidin-4yl)-N-phenyltetrahydrofuran-2-carboxamide);
18m. Tetrahydrothiofuranyl fentanyl (N-(1phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophen-2carboxamide);
19. Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-
N-phenylpropanamide);
20. Valeryl fentanyl (N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]pentanamide);
21. N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2’-fluoro ortho-fluorofentanyl; 2’-fluoro 2-fluorofentanyl);
22. N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4’-methyl acetyl fentanyl);
23. N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide ( i’-phenyl fentanyl; beta’-Phenyl fentanyl; 3phenylpropanoyl fentanyl);
24. N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide (i-methyl fentanyl);
25. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl
fentanyl);
26. N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
27. 2-methoxy-N-(2-methylphenyl)-N-(1phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
28. N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);
29. N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide
(phenyl fentanyl; benzoyl fentanyl);
30. N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl).
(nm) Furethidine;
(p) Hydroxypethidine;
(pm) Ketobemidone;
(q) Levomoramide;
(qm) Levophenacylmorphan;
(qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1yl)piperazin-1-yl)butan-1-one);
(r) Morpheridine;
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(rk) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
(rm) Noracymethadol;
(s) Norlevorphanol;
(sm) Normethadone;
(t) Norpipanone;
(tm) Phenadoxone;
(u) Phenampromide;
(um) Phenomorphan;
(v) Phenoperidine;
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4acetoxypiperidine);
(vm) Piritramide;
(w) Proheptazine;
(wm) Properidine;
(wn) Propiram;
(x) Racemoramide;
(xm) Synthetic Benzimidazole-opioid Substances, specifically including all of the following:
1. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
1m. Ethyleneoxynitazene (2-(2-((2,3-dihydrobenzofuran-5yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1amine).
2. Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).
4. Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro1H-benzimidazol-1-yl)ethan-1- amine).
5. Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5nitro-1H-benizimidazol-1-yl)ethan-1-amine).
5m. Methylenedioxynitazene or 3’,4’-methylenedioxynitazene (2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine).
5p. 5-methyl etodesnitazene (2-(2-(4-ethoxybenzyl)-5methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine).
6. Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-
1H-benzimidazol-1- yl)ethan-1-amine).
7. Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5nitro-1H-benzimidazol-1-yl)ethan-1-amine).
7b. N-desethyl etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro1H-benzimidazol-1-yl)-N-ethyethan-1-amine).
7e. N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
7h. N-desethyl protonitazene (N-ethyl-2-(5-nitro-2-(4propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine).
7k. N,N-dimethylamino etonitazene (2-(2-(4-ethoxybenzyl)-
5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine).
7m. N-piperidinyl etonitazene also known as etonitazepipne
(2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1Hbenzimidazole).
8. N-pyrrolidino etonitazene also known as etonitazepyne
(2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole).
8b. N-pyrrolidino isotonitazene (2-(4-isopropoxybenzyl)-5nitro-1-(2-(pyrrolindin-1-yl)ethyl)-1H-benzimidazole).
8e. N-pyrrolidino metonitazene also known as metonitazepyne (2-(4-methyoxbenzyl)-5-nitro-1-(2-(pyrrolidin-1yl)ethyl)-1H-benzimidazole).
8m. N-pyrrolidino protonitazene also known as protonitazepyne (5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1yl)ethyl)-1H-benzimidazole).
9. Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).
(xr) Tilidine;
(y) Trimeperidine.
(z) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-
N-methylbenzamide).
(zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).
(3) SUBSTANCES DERIVED FROM OPIUM. Any material, compound, mixture or preparation which contains any quantity of any
of the following substances derived from opium, including any of
their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
(a) Acetorphine;
(b) Acetyldihydrocodeine;
(c) Benzylmorphine;
(d) Codeine methylbromide;
(e) Codeine-N-oxide;
(f) Cyprenorphine;
(g) Desomorphine;
(h) Dihydromorphine;
(hm) Drotebanol;
(j) Etorphine, except its hydrochloride salts;
(k) Heroin;
(m) Hydromorphinol;
(n) Methyldesorphine;
(p) Methyldihydromorphine;
(q) Morphine methylbromide;
(r) Morphine methylsulfonate;
(s) Morphine-N-oxide;
(t) Myrophine;
(u) Nicocodeine;
(v) Nicomorphine;
(w) Normorphine;
(x) Pholcodine;
(y) Thebacon.
(4) HALLUCINOGENIC SUBSTANCES. Any material, compound, mixture or preparation which contains any quantity of any
of the following hallucinogenic substances, including any of their
salts, isomers, esters, ethers, and salts of isomers, esters, or ethers
that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or
chemically synthesized:
(a) 3,4-methylenedioxyamphetamine, commonly known as
“MDA”;
(ag) 3,4-methylenedioxyethylamphetamine, commonly
known as “MDE”;
(am) 3,4-methylenedioxymethamphetamine, commonly
known as “MDMA”;
(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
(b) 5-methoxy-3,4-methylenedioxyamphetamine;
(bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known
as “DOET”;
(c) 3,4,5-trimethoxyamphetamine;
(cm) Alpha-ethyltryptamine;
(d) Bufotenine;
(e) Diethyltryptamine;
(f) Dimethyltryptamine;
(g) 4-methyl-2,5-dimethoxyamphetamine, commonly known
as “STP”;
(h) Ibogaine;
(j) Lysergic acid diethylamide, commonly known as “LSD”;
(jm) 1-propionyl-lysergic acid diethylamide, commonly
known as 1P-LSD;
(m) Mescaline, in any form, including mescaline contained in
peyote, obtained from peyote or chemically synthesized;
(mn) Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6,
6, 9-trimethyl-6H-dibenzo(b, d)pyran);
(n) Phencyclidine, commonly known as “PCP”;
(p) N-ethyl-3-piperidyl benzilate;
(q) N-methyl-3-piperidyl benzilate;
(r) Psilocybin;
(s) Psilocin;
(sm) Salvinorin A;
(t) Tetrahydrocannabinols, commonly known as “THC”, in
any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana, or chemically synthesized, except that tetrahydrocannabinols do not include any of the
following:
1. Tetrahydrocannabinols contained in a cannabidiol product
that is dispensed as provided in s. 961.38 (1n) (a) or that is possessed as provided in s. 961.32 (2m) (b).
2. Tetrahydrocannabinols contained in fiber produced from
the stalks, oil or cake made from the seeds of a Cannabis plant,
any other compound, manufacture, salt, derivative, mixture or
preparation of the mature stalks (except the resin extracted therefrom), fiber, oil or cake or the sterilized seed of a Cannabis plant
which is incapable of germination.
3. Tetrahydrocannabinols contained in hemp, as defined in s.
94.55 (1).
4. A drug product in finished dosage formulation that has
been approved by the United States food and drug administration
that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-
2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from
cannabis and no more than 0.1 percent (w/w) residual
tetrahydrocannabinols.
(tb) Synthetic cannabinoids, including:
1. Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(Nmethyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(Nmethyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether
or not further substituted in the indole ring to any extent, whether
or not substituted in the naphthyl ring to any extent. Substances
specified under this subdivision include:
a. 1-pentyl-2-methyl-3-(1-naphthoyl)indole, commonly
known as JWH-007;
b. 1-propyl-2-methyl-3-(1-naphthoyl)indole, commonly
known as JWH-015;
c. 1-pentyl-3-(1-naphthoyl)indole, commonly known as
JWH-018 or AM-678;
d. 1-hexyl-3-(1-naphthoyl)indole, commonly known as
JWH-019;
e. 1-butyl-3-(1-naphthoyl)indole, commonly known as
JWH-073;
f. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, commonly
known as JWH-081;
g. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole,
commonly known as JWH-098;
h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole, commonly
known as JWH-122;
i. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole, commonly
known as JWH-164;
j. 1-[2-(4-(morpholinyl)ethyl)]-3-(1-naphthoyl)indole, commonly known as JWH-200;
k. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole, commonly
known as JWH-210;
L. 1-pentyl-3-(4-chloro-1-naphthoyl)indole, commonly
known as JWH-398;
m. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole, commonly
known as JWH-412;
n. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)indole, commonly known as AM-1220;
o. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole, commonly
known as AM-2201;
p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole, commonly known as MAM-2201;
q. 1-(5-chloropentyl)-3-(1-naphthoyl)indole, commonly
known as AM-2201 (5-chloropentyl);
r. 1-(5-bromopentyl)-3-(1-naphthoyl)indole, commonly
known as AM-2201 (5-bromopentyl);
s. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole, commonly
known as AM-2232;
t. (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone, commonly known as WIN 55,212-2;
2. Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole
ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent.
Substances specified under this subdivision include:
a. 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole, commonly known as JWH-307;
b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole,
commonly known as JWH-370;
c. 1-pentyl-3-(1-naphthoyl)pyrrole, commonly known as
JWH-030;
d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole, commonly
known as JWH-147;
3. Any compound structurally derived from 3-naphthylmethylindene by substitution at the 1-position of the indene ring
by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indene ring to any extent,
whether or not substituted in the naphthyl ring to any extent.
Substances specified under this subdivision include 1-pentyl-3-
(1-naphthylmethyl)indene, commonly known as JWH-176;
4. Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole
ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the phenyl ring to any extent. Substances specified under this subdivision include:
a. 1-pentyl-3-(4-methoxyphenylacetyl)indole, commonly
known as JWH-201;
b. 1-pentyl-3-(3-methoxyphenylacetyl)indole, commonly
known as JWH-302;
c. 1-pentyl-3-(2-methoxyphenylacetyl)indole, commonly
known as JWH-250;
d. 1-pentyl-3-(2-chlorophenylacetyl)indole, commonly
known as JWH-203;
e. 1-pentyl-3-(3-chlorophenylacetyl)indole, or 3-chloro isomer of JWH-203;
f. 1-pentyl-3-(4-chlorophenylacetyl)indole, or 4-chloro isomer of JWH-203;
g. 1-pentyl-3-(2-methylphenylacetyl)indole, commonly
known as JWH-251;
h. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole,
commonly known as RCS-8;
i. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2methoxyphenylacetyl)indole, commonly known as
cannabipiperidiethanone;
5. Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic
ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not substituted in the cyclohexyl ring to any extent.
Substances specified under this subdivision include:
a. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2yl)phenol, commonly known as CP 47,497;
b. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2yl)phenol, commonly known as CP 47,497 C8 homologue, or
cannabicyclohexanol;
6. Any compound structurally derived from 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring by
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent
and whether or not substituted in the phenyl ring to any extent.
Substances specified under this subdivision include:
a. 1-pentyl-3-(2-iodobenzoyl)indole, commonly known as
AM-679;
b. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole, commonly
known as AM-694;
c. 1-pentyl-3-(4-methoxybenzoyl)indole, commonly known
as RCS-4;
d. 1-butyl-3-(4-methoxybenzoyl)indole, commonly known
as RCS-4-C4 homologue;
e. 1-pentyl-3-(2-methoxybenzoyl)indole, commonly known
as RCS-4 2-methoxy isomer;
f. 1-butyl-3-(2-methoxybenzoyl)indole, a C4 homologue, 2methoxy isomer of RCS-4;
g. 1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)indole, commonly known as pravadoline, or WIN 48,098;
h. 1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodo-indole, commonly known as 6-iodopravadoline, or
AM-630;
i. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodo-5-nitrobenzoyl)indole, commonly known as AM-1241;
j. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)indole, commonly known as AM-2233;
7. Any compound structurally derived from 3-adamantoylindole by substitution at the nitrogen atom of the indole ring with
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the adamantyl ring to any extent.
Substances specified under this subdivision include:
a. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-adamantoyl)indole, commonly known as AM-1248;
b. 1-pentyl-3-(1-adamantoyl)indole, commonly known as
AB-001;
8. Any compound structurally derived from 3-(cyclopropoyl)indole by substitution at the nitrogen atom of the indole
ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the cyclopropyl ring to any extent.
Substances specified under this subdivision include:
a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as UR-144;
b. 1-(5-chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as 5Cl-UR-144;
c. 1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as XLR-11;
d. 1-[2-(4-morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as A-796,260;
e. 1-[(tetrahydropyran-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as A-834,735;
9. Any compound structurally derived from N-adamantyl1H-indole-3-carboxamide by substitution at the nitrogen atom of
the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted
in the adamantyl ring to any extent. Substances specified under
this subdivision include:
a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide,
commonly known as 2NE1;
b. N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide, commonly known as STS-135;
10. Any compound structurally derived from N-adamantyl1H-indazole-3-carboxamide by substitution at either nitrogen
atom of the indazole ring with alkyl, haloalkyl, cyanoalkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indazole ring to any extent, whether or not substituted in the adamantyl ring to any extent. Substances specified
under this subdivision include:
a. 1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide,
commonly known as AKB48;
b. 1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly known as 5F-AKB48.
11. Any compound structurally derived from N-naphthyl1H-indazole-3-carboxamide by substitution at either nitrogen
atom of the indazole ring with alkyl, haloalkyl, cyanoalkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indazole ring to any extent, whether or not substituted in the naphthyl ring to any extent.
12. [1,1’-biphenyl]-3-yl-carbamic acid, cyclohexyl ester,
commonly known as URB-602;
13. [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate, commonly known as CP 50,556-1;
14. (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol,
commonly known as HU-210;
15. (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol,
commonly known as HU-211;
16. 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione, commonly known as HU-331;
17. ((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol, commonly known as JWH-051;
18. (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as
JWH-133;
19. (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2trimethylbutyl]-6a,7,10,10a-tetrahydrobenzo[c]chromene, commonly known as JWH-359;
20. Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone,
commonly known as CB-13;
21. N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecamide, commonly known as CB-25;
22. N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecamide, commonly known as CB-52;
23. N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8pentyloxy-1,2-dihydroquinoline-3-carboxamide, commonly
known as JTE-907;
24. N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide, commonly known as A-836,339;
25. Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-
1H-indol-3-yl}methanone, commonly known as WIN 56,098;
26. 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one, commonly known as URB-754;
27. [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate,
commonly known as URB-597;
28. (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4trifluorobutyl-1-sulfonate, commonly known as BAY 38-7271.
29. Any compound structurally derived from 1H-indole-3carboxylic acid quinolinyl ester by substitution at the nitrogen
atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted
in the quinoline ring to any extent. Substances specified under
this subdivision include:
a. 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester,
commonly known as PB-22;
b. 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as 5F-PB-22;
c. 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8quinolinyl ester, commonly known as BB-22.
30. Any compound structurally derived from N-naphthyl1H-indole-3-carboxamide by substitution at the nitrogen atom of
the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted
in the naphthyl ring to any extent. Substances specified under
this subdivision include:
a. 1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as NNEI or MN-24;
b. 1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as 5F-NNEI or 5F-MN-24.
31. Any compound structurally derived from 3-(pyridinoyl)indole by substitution at the nitrogen atom of the indole ring
by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent,
whether or not substituted in the pyridine ring to any extent. Substances specified under this subdivision include:
a. 1-pentyl-3-(3-pyridinoyl)indole;
b. 1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.
32. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as ABFUBINACA.
32m. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl1H-indazole-3-carboxamide, commonly known as ADBBUTINACA.
33. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl1H-indazole-3-carboxamide, commonly known as ADBPINACA.
34. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as ABCHMINACA.
35. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as AB-PINACA).
36. [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1yl)methanone, commonly known as THJ-2201.
37. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as
MAB-CHMINACA or ADB-CHMINACA.
38. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-ADB.
38m. Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 4F-MDMBBINACA or 4F-MDMB-BUTINACA.
39. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as 5F-AMB.
40. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as
ADB-FUBINACA.
41. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMBCHMICA.
42. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as MDMBFUBINACA.
43. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as FUB-AMB,
MMB-FUBINACA or AMB-FUBINACA.
43m. Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-FUBICA or
AMB-FUBICA.
44. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly known as NM2201.
45. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, commonly known as 5FAB-PINACA.
46. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole3-carboxamide, commonly known as 4-CN-CUMYLBUTINACA.
47. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-CHMICA.
48. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-
pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5FCUMYL-P7AICA.
49. Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-EDMBPINACA.
50. Methyl 2-(1-(5-fluoropentyl)-1-indole-3-carboxamido)-
3,3-dimethylbutanoate, commonly known as 5F-MDMB-PICA.
51. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboxamide, commonly known as FUB-AKB48, FUB-APINACA or AKB48 N-(4-FLUOROBENZYL).
52. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 5F-CUMYL-PINACA
or SGT-25.
53. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, commonly known as FUB-144.
54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole3-carboxamido)butanoate, commonly known as MDMB-4enPINACA.
55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-
3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.
56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4en-1-yl)-1H-indazole-3-carboxaminde, commonly known as
ADB-4en-PINACA.
57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1one, commonly known as CUMYL-PEGACLONE or SGT-151.
58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-
3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA
or 5F-EDMB-2201.
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
(ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
(uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone,
commonly known as methoxetamine.
(v) 2,5-dimethoxyamphetamine;
(w) 4-bromo-2,5-dimethoxyamphetamine, commonly known
as “DOB”;
(wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known
as DOI.
(wb) 4-chloro-2,5-dimethoxyamphetamine, commonly
known as DOC.
(wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-B” or “Nexus”;
(wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-I”.
(wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as “2C-T-7”;
(wi) Alpha-methyltryptamine, commonly known as “AMT”;
(wj) 5-methoxy-N, N-diisopropyltryptamine, commonly
known as “5-MeO-DIPT”;
(wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly
known as 2C-E.
(wL) 2,5-dimethoxy-4-methylphenethylamine, commonly
known as 2C-D.
(wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly
known as 2C-C.
(wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly
known as 2C-T-2.
(wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.
(wp) 2,5-dimethoxyphenethylamine, commonly known as
2C-H.
(wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly
known as 2C-N.
(wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly
known as 2C-P.
(ws) Any compound structurally derived from N-benzyl-2-
(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen
atom, or on either ring, with alkyl, alkoxy, alkylenedioxy,
haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this
paragraph include:
1. 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine, commonly known as 25INBOMe.
2. 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine, commonly known as 25CNBOMe.
3. 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl)methyl]ethanamine, commonly known as 25BNBOMe.
4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.
(wv) N,N-diallyl-5-methoxytryptamine, commonly known as
5-MeO-DALT.
(ww) 5-(2-aminopropyl)benzofuran, commonly known as 5APB.
(wx) 6-(2-aminopropyl)benzofuran, commonly known as 6APB.
(wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly
known as 5-APDB.
(wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly
known as 6-APDB.
(x) 4-methoxyamphetamine, commonly known as “PMA.”
(xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
(xb) 4-methoxymethamphetamine, commonly known as
PMMA.
(5) DEPRESSANTS. Any material, compound, mixture or
preparation which contains any quantity of any of the following
substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that
are theoretically possible within the specific chemical
designation:
(aa) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H
-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ab) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3dihydro-2 H -benzo[ e][1,4]diazepin-2-one).
(ac) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H
-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ad) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4
H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ae) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ag) Gamma-hydroxybutyric acid (commonly known as
gamma hydroxybutyrate or “GHB”), gamma-butyrolactone, and
1,4-butanediol.
(am) Mecloqualone.
(b) Methaqualone.
(7) STIMULANTS. Any material, compound, mixture or
preparation which contains any quantity of any of the following
substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that
are theoretically possible within the specific chemical
designation:
(ag) Cathinone.
(am) Aminorex.
(b) Fenethylline.
(c) N-ethylamphetamine.
(cm) 4,4’-Dimethylaminorex.
(d) 4-methylaminorex.
(e) N,N-dimethylamphetamine.
(L) Substituted cathinones. Any compound, except bupropion
or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the
1-position with either phenyl, napthyl, or thiophene ring systems,
whether or not the compound is further modified in any of the
following ways: by substitution in the ring system to any extent
with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring system
by one or more other univalent substituents; by substitution at the
3-position with an acyclic alkyl substituent; by substitution at the
2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a
cyclic structure; or by any combination of these modifications.
Substances specified under this subdivision include:
1. Methcathinone.
2. Methylenedioxypyrovalerone, commonly known as
MDPV.
2m. 3-methylmethcathinone or 2-(methylamino)-1-(3methylphenyl)propan-1-one, commonly known as 3-MMC.
3. 4-methylmethcathinone, commonly known as
mephedrone or 4-MMC.
4. 4-methylethcathinone, commonly known as 4-MEC.
5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly
known as MOPPP.
6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone,
commonly known as MDPPP.
7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.
8. 2-fluoromethcathinone, commonly known as 2-FMC.
9. 3-fluoromethcathinone, commonly known as 3-FMC.
10. 4-fluoromethcathinone, commonly known as 4-FMC or
flephedrone.
11. 3,4-methylenedioxymethcathinone, commonly known as
methylone or bk-MDMA.
12. Naphthylpyrovalerone, commonly known as naphyrone.
13. 4-methyl-alpha-pyrrolidinobutiophenone, commonly
known as MPBP.
14. 4-methoxymethcathinone, commonly known as methedrone or bk-PMMA.
15. Ethcathinone.
16. 3,4-methylenedioxyethcathinone, commonly known as
ethylone or bk-MDEA.
17. beta-Keto-N-methylbenzodioxolylbutanamine, commonly known as butylone or bk-MBDB.
18. N,N-dimethylcathinone, commonly known as
metamfepramone.
19. Alpha-pyrrolidinopropiophenone, commonly known as
alpha-PPP.
20. 3-methoxymethcathinone, commonly known as 3-MMC.
21. 4-ethylmethcathinone, commonly known as 4-EMC.
22. 3,4-dimethylmethcathinone, commonly known as 3,4DMMC.
23. beta-Keto-N-methylbenzodioxolylpentanamine, commonly known as pentylone or bk-MBDP.
24. beta-Keto-ethylbenzodioxolylbutanamine, commonly
known as eutylone or bk-EBDB.
25. 4-bromomethcathinone, commonly known as 4-BMC.
26. Alpha-methylamino-butyrophenone, commonly known
as buphedrone or MABP.
27. 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone,
commonly known as MDPBP.
28. 4-methyl-alpha-pyrrolidinohexiophenone, commonly
known as MPHP.
29. N,N-dimethyl-3,4-methylenedioxycathinone.
30. N,N-diethyl-3,4-methylenedioxycathinone.
31. Alpha-methylamino-valerophenone, commonly known
as pentedrone.
32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly
known as 4-MePPP.
33. Alpha-pyrrolidinobutiophenone, commonly known as aPBP.
34. N-Ethylpentylone, commonly known as ephylone.
35. N-Ethylhexedrone.
36. Alpha-pyrrolidinohexanophenone, commonly known as
a-PHP.
36m. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one,
commonly known as alpha-PiHP.
37. 4-methyl-alpha-ethylainopentiophenone, commonly
known as 4-MEAP.
38. 4’-methyl-alpha-pyrrolidinohexiophenone, commonly
known as MPHP.
39. Alpha-pyrrolidinoheptaphenone, commonly known as
PV8.
40. 4’-chloro-alpha-pyrrolidinovalerophenone, commonly
known as 4-chloro-a-PVP.
41. 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1one, commonly known as dipentylone or N,Ndimethylpentylone.
42. 1-(4-chlorophenyl)-2-(methylamino)propan-1-one, commonly known as 4-chloromethcathinone, or 4-CMC.
(mk) Mitragynine.
(mL) 7-hydroxymitragynine.
(mm) 5,6-methylenedioxy-2-aminoindane, commonly known
as MDAI.
(mn) Benzothiophenylcyclohexylpiperidine, commonly
known as BTCP.
(p) 4-methylthioamphetamine, commonly known as “4MTA.”
(q) N- benzylpiperazine, commonly known as “BZP.”
(r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5yl)amino]heptanoic acid, commonly known as Amineptine.
(s) N-phenyl-N’-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3ium-5-yl)carbamimidate, commonly known as Mesocarb.
(t) N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly
known as Methiopropamine.
(u) Ethyl 2-phenyl-2-(piperidin-2-yl)acetate, commonly
known as Ethylphenidate.
(v) 1-(4-fluorophenyl)propan-2-amine, commonly known as
4-fluoroamphetamine, para-fluoroamphetamine, or 4-FA.‹ Prev All Wisconsin sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.